Blog

MSC Therapy for Diabetic Foot Ulcers: 2026 Mechanism, Hydrogel Delivery, and Real-World Trial Outcomes

2026 medical update on MSC therapy for diabetic foot ulcers: M2 macrophage polarization, EXO-miR3671 angiogenesis, hydrogel delivery, UC-MSC vs ADSC head-to-head, 47-RCT meta-analysis, and cost-effectiveness vs amputatio…

Aug 18, 2026

The First FDA-Approved Stem Cell Therapy for Type 1 Diabetes: What Zimislecel Means for Patients in 2026

Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026,…

Aug 13, 2026

Healing Chronic Wounds with Stem Cells: A New Frontier for Diabetic Patients

Diabetic wounds that refuse to heal affect hundreds of thousands of Thais. Discover how exosome therapy and MSC treatment are giving patients a real path to recovery.

May 29, 2026

Can Stem Cells Reverse Diabetes? What Thai Patients Should Know in 2026

Diabetes affects millions across Thailand. Can stem cell therapy help reverse it? Our Bangkok clinic shares real patient outcomes, THB pricing, and what the latest research says about stem cells for diabetes in 2026.

May 25, 2026

Stem Cells vs. Type 1 Diabetes: Are We on the Cusp of a Cure?

Type 1 diabetes has long been considered a lifelong condition, requiring constant management and insulin therapy. However, recent developments in stem cell research are challenging this notion and offering hope for a pot…

Feb 10, 2025

Groundbreaking Advances in Stem Cell Therapy for Type 1 Diabetes

In a landmark development for stem cell research and diabetes treatment, Vertex Pharmaceuticals has achieved remarkable success with their investigational therapy VX-880 for type 1 diabetes (T1D). This breakthrough, base…

Jan 9, 2025

Un pas de plus vers la thérapie par cellules souches pour le diabète de type 1

Les scientifiques développent une approche prometteuse pour traiter le diabète de type 1 en utilisant des cellules souches pour créer des cellules productrices d'insuline (appelées cellules bêta) qui pourraient remplacer les cellules pancréatiques non fonctionnelles.

Aug 3, 2021

Gène musculaire lié au diabète de type 2

Les personnes atteintes de diabète de type 2 ont tendance à avoir une fonction musculaire plus faible que les autres. Aujourd'hui, une équipe de recherche a découvert que dans le diabète de type 2, un gène spécifique est d'une grande importance pour la capacité des cellules souches musculaires à créer de nouvelles cellules musculaires matures.

May 5, 2021

Page 1 of 1 — 8 posts